User contributions
For
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 15:41, 29 July 2017 (diff | hist) . . (+1,589) . . Selenium
- 14:46, 29 July 2017 (diff | hist) . . (+34) . . DHA
- 14:45, 29 July 2017 (diff | hist) . . (+2,922) . . DHA
- 14:32, 29 July 2017 (diff | hist) . . (+25) . . Benfotiamine
- 14:30, 29 July 2017 (diff | hist) . . (+296) . . N 3nB (Created page with "Information on nutritional supplements people with ALS have been taking == Effects on ALS == === Regulated pathways === ==Possible synergies== ==Cautions and risks==...")
- 14:28, 29 July 2017 (diff | hist) . . (+244) . . Selenium
- 14:27, 29 July 2017 (diff | hist) . . (+185) . . Glutathione
- 14:26, 29 July 2017 (diff | hist) . . (+184) . . Citicoline
- 14:25, 29 July 2017 (diff | hist) . . (+182) . . Benfotiamine
- 14:24, 29 July 2017 (diff | hist) . . (+51) . . DHA
- 14:24, 29 July 2017 (diff | hist) . . (+48) . . R Alpha Lipoic Acid (R-ALA)
- 14:23, 29 July 2017 (diff | hist) . . (+136) . . R Alpha Lipoic Acid (R-ALA)
- 14:22, 29 July 2017 (diff | hist) . . (+322) . . DHA
- 14:18, 29 July 2017 (diff | hist) . . (+279) . . N DHA (Created page with " Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is a primary structural component of the human brain, cerebral cortex, skin, and retina. It can be synthesized from a...")
- 14:17, 29 July 2017 (diff | hist) . . (+204) . . Information on nutritional supplements people with ALS have been taking
- 18:54, 20 July 2017 (diff | hist) . . (+1) . . Translations:Dave Johnson's Proletariat Protocol/74/fi (current)
- 18:54, 20 July 2017 (diff | hist) . . (+1) . . Dave Johnson's Proletariat Protocol/fi (current)
- 18:41, 20 July 2017 (diff | hist) . . (-3) . . Translations:Dave Johnson's Proletariat Protocol/17/fi (current)
- 18:41, 20 July 2017 (diff | hist) . . (-3) . . Dave Johnson's Proletariat Protocol/fi
- 18:38, 20 July 2017 (diff | hist) . . (+3) . . Translations:Dave Johnson's Proletariat Protocol/11/fi (current)
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)